Related Experiment Video
Updated: May 6, 2026

A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy
Published on: May 16, 2015
Brain hypothermic therapy dramatically decreases elevated blood concentrations of high mobility group box 1 in
Toshihiko Nakamura1, Shingo Yamada, Toshirou Yoshioka
1National Hospital Organization, Nishisaitama-Chuo National Hospital, Japan.
Insights
Brain hypothermic therapy (BHT) significantly reduces high mobility group box 1 (HMGB1) levels in neonates with hypoxic-ischemic encephalopathy (HIE). HMGB1 serves as a key indicator for inhibiting early-stage inflammation following BHT.
Area of Science:
- Neonatal Medicine
- Neurology
- Biochemistry
Background:
- Hypoxic-ischemic encephalopathy (HIE) in neonates often requires brain hypothermic therapy (BHT) as per ILCOR Consensus 2010.
- High mobility group box 1 (HMGB1) elevation is implicated in inflammatory cytokine release during early brain ischemia-reperfusion injury.
Purpose of the Study:
- To investigate the impact of BHT on HMGB1 levels in neonates with HIE.
- To assess HMGB1 as a potential biomarker for early inflammation inhibition.
Main Methods:
- Plasma HMGB1 concentrations were measured in 21 neonates.
- Groups included: 8 neonates with HIE undergoing BHT (BHT+), 5 neonates with HIE not receiving BHT (BHT-), and 8 normal controls.
Main Results:
- Umbilical artery HMGB1 (UA-HMGB1) levels were significantly elevated before BHT in the BHT+ group.
- UA-HMGB1 levels in the BHT- group were not significantly different from reference values initially but increased 24 hours post-birth.
- Repeated measure ANOVA revealed significant differences in time-course changes between BHT+ and BHT- groups (P = 0.0002).
Conclusions:
- Brain hypothermic therapy effectively decreases HMGB1 levels in neonates with HIE.
- HMGB1 is a valuable biomarker for monitoring the inhibition of early-stage inflammation in neonatal brain injury.
Background:
According to the Consensus 2010 of the International Liaison Committee on Resuscitation (ILCOR), children with moderate to severe hypoxic-ischemic encephalopathy (HIE) should receive brain hypothermic therapy (BHT) after successful resuscitation. Elevated high mobility group box 1 (HMGB1) in the blood at the early stage of brain ischemia-reperfusion injury has been suggested to be involved in the release of various inflammatory cytokines.
Methods:
In total, 21 neonates plasma HMGB1 concentration was measured. These neonates included 8 with HIE in whom BHT was indicated, 5 controls diagnosed as having HIE but who were not suitable candidates for BHT, and 8 normal controls.
Results:
The umbilical artery HMGB1 (UA-HMGB1) level before undergoing BHT significantly exceeded reference values. The UA-HMGB1 level in the BHT (-) group did not differ significantly from reference values, but was significantly increased 24 hours after birth. Repeated measure ANOVA showed a significant difference in time course changes between the BHT (+) and BHT (-) groups (P = 0.0002).
Conclusions:
This study demonstrated hypothermic therapy to significantly decrease HMGB1. Furthermore, HMGB1 is a useful index of the inhibition of early stage inflammation.
Related Concept Videos
Decreased Body Temperature
Methods of reducing fever
Pharmacological Methods of Reducing Fever:

